Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I
Diem N. Nguyen(United States Military Academy), Carolyn A. Buser(United States Military Academy), Robert B. Lobell(United States Military Academy), Craig A. Stump(United States Military Academy), Eileen S. Walsh(Janssen (Switzerland)), Joseph P. Davide(United States Military Academy), Theresa M. Williams(United States Military Academy), R. Robinson(United States Military Academy), Hans E. Huber(Health Strat (Kenya)), Christine Fernandes(United States Military Academy), Michelle Ellis-Hutchings(United States Military Academy)
Cited by 22
Related Papers
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors
|Biochemical Journal|2005|396
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage
|Cancer Cell|2005|271
Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
|Molecular Therapy|2009|209
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|Blood|2020|167
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|157